F. Hoffmann La Roche AG: Facility of the Year Award for Project Execution
DSP production area.
Headquartered in Basel, Switzerland, Roche is one of the world’s leading research-focused healthcare groups in the fields of pharmaceuticals and diagnostics. To increase production capacity for its innovative cancer drugs, Roche constructed two new biotech production facilities – one at the Roche site in Penzberg ( Germany ), one of the world’s largest biotech centers. The new plant “Biologics IV” is four stories high and consists of two highly automated production lines – each containing three 12,500 Liter fermenters and a downstreaming processing – as well as associated laboratory and office accommodation. It represents an investment of 290 Million Euro.
Technician inspecting product.
The construction project was run as an ultra fast track project and the new plant was designed, built and put into operation within only three years. The new facility is initially used to manufacture the active ingredient of the anti-breast cancer drug Herceptin. Roche has created about 150 new jobs to operate the new facility. Once running at full capacity, Biologics IV will enable the supply for 100,000 additional Herceptin patients per year.
Architects
Koppenhöfer & Partner GmbH
Engineering Contractor
LSMW GmbH – Total Life Science Solutions
Construction Manager
SIBC GmbH – A Turner & Townsend Company
Pharmaceutical Processing Advantage Business Media
